New findings add to the pile of research on the possible neuroprotective effects of drugs like dapagliflozin, empagliflozin, and dulaglutide for patients with type 2 diabetes. New research ...

Patients with type 2 diabetes treated with sodium-glucose cotransporter-2 (SGLT-2) inhibitors have a significantly lower risk of developing dementia and Alzheimer's disease than those receiving ...

The team focussed on one relatively new drug, sodium-glucose cotransporter-2 (SGLT-2) inhibitors, comparing it to dipeptidyl peptidase-4 (DPP-4) inhibitors in terms of reducing dementia risk. SGLT2 ...

MADRID — Nearly half of people with type 2 diabetes (T2D) currently recommended to receive sodium-glucose cotransporter 2 (SGLT2) inhibitors for kidney protection would not actually benefit from ...

The researchers found that during a median follow-up of 4.4 years, the primary outcome event of presumed clinical onset of dementia occurred in 69 and 43 participants in the SGLT2 and dulaglutide ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors — a class of drugs used to treat type 2 diabetes — could also prevent dementia, according to a study published Wednesday in The BMJ.

Apple's annual iPhone event is scheduled to take place on Monday, September 9. Typically, this would suggest that iPhone 16 pre-orders would begin on Friday, September 13, but German blog ...

Further, treatment with SGLT-2 drugs over a long duration was found to have more pronounced effects -- a 48 per cent reduced risk of dementia for more than two years of treatment. Examples of SGLT ...

Devastated brides have revealed the joy of their wedding day has been somewhat “sabotaged” as they make desperate attempts to obtain the video footage taken by the company they hired.

When Donald Trump launched his first presidential campaign nearly a decade ago, there was a deluge of concerns about his foreign financial entanglements. And rightfully so. Given the financial ...

A class of drugs used to treat diabetes, called sodium-glucose cotransporter-2 (SGLT-2) inhibitors, cut the risk of a type 2 diabetes patient developing dementia by more than a third compared to ...